Clinical Trial Update: Sequential Endoscopic Lung Volume Reduction [Phase 3]

View source ↗

Summary

Phase 3 trial of sequential endoscopic lung volume reduction in emphysema/COPD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Heidelberg University | Conditions: Emphysema, COPD | Phase 3 | Status: WITHDRAWN